Related Experiment Video
Updated: Jun 16, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
Beyond the BMI: the search for better guidelines for bariatric surgery
Walter J Pories1, Lynis G Dohm, Christopher J Mansfield
1Department of Surgery, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA. Pories@aol.com
The body mass index (BMI) of 35 is an outdated benchmark for bariatric surgery access. New guidelines are needed as BMI does not accurately assess obesity or its risks, and surgery shows promise for diabetes remission even at lower BMIs.
Area of Science:
- Bariatric surgery
- Obesity management
- Metabolic disease
Background:
- Current guidelines use a body mass index (BMI) of 35 or greater as a primary requirement for bariatric surgery access.
- This BMI threshold is incorporated into policies by Medicare, Medicaid, and most private insurers.
- The BMI index has limitations in accurately reflecting adiposity, potentially leading to unfair discrimination based on gender, race, age, fitness, and body fat composition.
Purpose of the Study:
- To evaluate the appropriateness of using BMI >= 35 as the main prerequisite for bariatric surgery.
- To advocate for new guidelines considering emerging evidence on bariatric surgery's effectiveness in managing comorbidities.
Main Methods:
- Review of current bariatric surgery access criteria.
- Analysis of the limitations of BMI as a sole indicator of obesity and surgical candidacy.
- Examination of evidence regarding bariatric surgery's impact on comorbidities like type 2 diabetes.
Main Results:
- The BMI of >= 35 is deemed inappropriate due to its failure to account for adiposity distribution and its potential for discriminatory application.
- Emerging evidence indicates bariatric surgery can achieve significant and lasting remission of type 2 diabetes, even in patients with BMIs below 30.
- Current guidelines may exclude patients who could benefit from surgery and include those who may not require it based solely on BMI.
Conclusions:
- The reliance on BMI >= 35 for bariatric surgery access is no longer appropriate.
- New guidelines are necessary to ensure equitable access and optimize patient outcomes.
- Bariatric surgery shows potential for treating type 2 diabetes and other comorbidities, even in individuals with lower BMI values, necessitating a re-evaluation of eligibility criteria.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity
Drug Dosing: Obese Patients
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

